Yale

When it comes to eluding detection, HIV and cancer cells are at the top of the class. As such, the few treatments currently available to sufferers of HIV or prostate cancer are generally expensive, often hard to manufacture, and come packaged with a smattering of unpleasant side effects. But Yale researchers have now developed synthetic molecules that help the body recognize HIV and prostate cancer cells as threats, tricking the body into initiating an immune response that it normally would not.